secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001104659-25-098082
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics closes $58.9M private placement led by Winklevoss Capital to pursue digital asset treasury
--------------------------------------------------------------------------------

- Gross proceeds of ~$58.88M from sale of 15.2M shares, 80.8M pre-funded warrants, and 72.0M common warrants.
- Winklevoss Capital leads the deal; gets right to nominate two board members, one of whom will serve as chair.
- Proceeds to fund a digital asset treasury strategy and continue development of FL-501 and sirexatamab.
- Common warrants priced at $0.5335/share, 10-year term; pre-funded warrants exercisable at $0.001/share with no expiration.
- Parcrest serves as placement agent; receives $1.5M fee ($1M cash plus warrants for 4M shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/0001104659-25-098082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465925098082/tm2528058d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-098082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer